This is consistent with the glucagon receptor activation driving increased sympathetic tone and thermogenesis
Full publication of combination-therapy data is awaited, however interim analysis from the phase II COURAGE trial (NCT06299098) found 3.3% reduction in lean mass of obese patients treated with the combination of trevogrumab and semaglutide, compared with 6.5% reduction with semaglutide alone [70]
More than just obesity treatment Tirzepatide mimics two hormones that help regulate hunger, blood sugar, and metabolism: GLP-1 and GIP
Both medications can be taken as prescribed, but patients should monitor for any unusual symptoms
Known as the "master antioxidant," glutathione is essential for neutralizing free radicals, optimizing immune defense, and supporting overall cellular function
Low birth weight, exposure to androgens in the womb, and exposure to hormone disruptors may also predispose people to PMOS